Skip to main content

Table 1 Study population characteristics and demographic variables by fibroid outcome

From: Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure

 

n

Fibroid Cases

(N = 608)

Fibroid Controls

(N = 3,181)

Mean(SD) or %

Mean(SD) or %

Age (years), mean (SD)

3,789

47(13)

44(18)

Race/ethnicity

 European American, non-Hispanic

2,502

56%

68%

 African American, non-Hispanic

835

35%

19%

 Hispanic ethnicity

73

2%

2%

 Asian

45

1%

1%

 Other

92

1%

3%

 Missing

242

5%

7%

BMI (kg/m2), mean (SD)

2,496

34 (10)

32 (11)

 Underweight (<20)

128

2%

4%

 Normal weight (20–24)

468

11%

13%

 Overweight (25–29)

610

21%

15%

 Obese (≥30)

1,290

48%

31%

 Missing

1,293

18%

37%

T2D diagnosis

 Yes (%)

714

17%

19%

 No (%)

3,075

83%

81%

Diabetes treatmentsa

 Insulin

406

9%

12%

 Metformin

360

11%

10%

 Thiazolidinedione

133

5%

4%

 Other medications

84

2%

3%

  1. BMI body mass index, SD standard deviation
  2. aTreatment percentages sum up to greater than 100% because women could have been on more than one treatment